INTERLEUKINE EARLY RISK MARKERS OF ACUTE REJECTION IN KIDNEY TRANSPLANTATION
- Authors: Fedorenko T.V.1, Kolesnikova N.V.1, Filippov E.F.1
-
Affiliations:
- Kuban state medical University
- Issue: Vol 20, No 3 (2017)
- Pages: 541-543
- Section: Articles
- URL: https://journal-vniispk.ru/1028-7221/article/view/119973
- ID: 119973
Cite item
Full Text
Abstract
About the authors
T. V. Fedorenko
Kuban state medical University
Author for correspondence.
Russian Federation
N. V. Kolesnikova
Kuban state medical UniversityRussian Federation
E. F. Filippov
Kuban state medical UniversityRussian Federation
References
- Bertani A. Overcoming primary graft dysfunction after lung transplantation: are we finding our way there? / Bertani A. // Transplantation.- 2014.-№ 97.- Р. 1100-1101.
- Taniguchi M. Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies/ Taniguchi M., Rebellato L. M., Cai J., Hopfield J., Briley K. P., Haisch C. E., Catrou P. G., Bolin P., Parker K., Kendrick W. T., et al. // Am J Transplant.- 2013.- № 13.- Р. 2577-2589.
- Porcheray F. Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement./ Porcheray F., Fraser J. W., Gao B., McColl A., DeVito J., Dargon I., Helou Y., Wong W., Girouard T. C., Saidman S. L., et al.// Am J Transplant.- 2013.-№ 13.- Р. 2590-2600.
- Li X. C. The significance of non-T-cell pathways in graft rejection: Implications for transplant tolerance / Transplantation.- 2010.- Vol. 90.- Р.1043-1047.
- Carvalho-Gaspar M. Chemokine gene expression during allograft rejection: Comparison of two quantitative PCR techniques / M. Carvalho-Gas-par, J. S. Billing, B. M. Spriewald, et al. // JImmunol Methods.- 2005.- Vol. 301.- Р.41-52.
Supplementary files

